Skip to main content
OpenTrials
Completed

NCT Number: NCT03179670

Interest of a Systematic Assessment of the Treatment of LUTS in the Management of BPH

The high level of unsatisfactory outcome observed in patients treated for LUTS associated with BPH with respect to the different existing therapeutic options strongly emphasizes the need for treatment optimisation in daily practice by a careful LUTS monitoring and treatment adjustment when needed. The poorer outcome observed in patients for whom treatment has been initiated recently suggests that the duration of the disease itself may influence the patient satisfaction.To achieve this goal, we propose to systematically assess LUTS associated with BPH in patients treated for at least 6 months and to assess whether an alpha-blocker therapy initiation/modification may improve the outcome in case of persisting symptoms. We also investigate the influence of the symptom duration on the frequency of unsatisfactory outcome.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Benign Prostatic Hyperplasia Genital Diseases Genital Diseases, Male Male Urogenital Diseases Prostatic Diseases Prostatic Hyperplasia Urogenital Diseases

Age range

60 year and older

Sex eligibility

Male

Study type

Observational

Primary location

LBR

Puteaux, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients aged 60 years or more suffering from LUTS/BPH AND medically treated for at least 6 months.

Exclusion criteria

  • Patients with prostate cancer
  • Patients requiring surgical treatment
  • The absence of Lower Urinary Tract Symptoms
  • Treatment initiation for less than 6 months
  • Cognitive disorders or other pathologies leading to the inability to give its consent to the collection of data.
  • Refusal to participate.

Treatment and study plan

Primary outcomes

  1. Percentage of patients treated for LUTS associated with BPH displaying unsatisfactory outcome after at least 6 months of treatment and not requiring surgical treatment.

    Time frame: 6 months

Sponsors and collaborators

Lead sponsor

RECORDATI GROUP

Industry

Collaborators

  • ClinSearch

Registry information

Official study title

Interest of a Systematic Assessment of the Treatment of Lower Urinary Tract Symptoms (LUTS) in the Management of Benign Prostatic Hyperplasia (BPH) in Urology

Acronym: UROEVAL

Important dates

Study start
2017
Primary completion
2018
Study completion
2018
First posted
Jun 7, 2017
Registry last updated
Jun 19, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.